Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Vodafone Idea and 4 other midcap stocks hit 52-week highs, rally up to 40% in a month
Benchmark indices ended marginally higher as five BSE 150 Midcap stocks touched fresh 52-week highs, reflecting strong investor sentiment and bullish momentum. Vodafone Idea, SAIL, MCX, Laurus Labs and Ajanta Pharma recorded notable monthly gains, signalling sustained buying interest despite subdued broader market performance overall.
Laurus Labs Ltd spurts 1.07%, rises for fifth straight session
Laurus Labs Ltd is quoting at Rs 1280.4, up 1.07% on the day as on 12:44 IST on the NSE. The stock is up 115.1% in last one year as compared to a 4.28% drop in NIFTY and a 12.36% drop in the Nifty Pharma.
Laurus Labs Ltd soars 1.75%, Gains for third straight session
Laurus Labs Ltd is quoting at Rs 1227.6, up 1.75% on the day as on 12:49 IST on the NSE. The stock is up 108.49% in last one year as compared to a 0.68% gain in NIFTY and a 14.53% gain in the Nifty Pharma index.
Dividend alert! Last date to buy these 10 stocks before they go ex-record date. Do you own?
Investors have a final opportunity today to purchase shares of 10 companies before they go ex-record date for dividends tomorrow, May 8. Notable companies include Central Bank of India, Laurus Labs, NALCO, and Premier Energies, with dividend payouts varying across the listed firms.
Market Trading Guide: 5 stock ideas for gains up to 11% on Tuesday
Nifty ended higher amid positive election sentiment but faced resistance near 24,200. Analysts see support at 24,000, maintaining a bullish bias above key levels. Experts recommend selective trades, suggesting buying stocks like Adani Ports and Laurus Labs, while cautioning on CDSL weakness.
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore. Full-year net profit surged 148% to Rs 889 crore, driven by strong growth in its CDMO and Generics divisions. The company also announced an interim dividend of Rs 1.20 per share.
Q4 Results LIVE Updates: Sundram Fasteners profit up 30%; ESAF SFB NII grows 20%
Q4 Results LIVE Updates: Today is the busiest day in terms of quarterly results this week. The big earnings reaction of the day comes from Bajaj Finance where brokerages have raised their targets and even upgraded the stock, along with Waaree Energies, who also issued its guidance for FY27. The biggest result of the day comes from Hindustan Unilever (HUL), followed by Adani twins on the Nifty (Ports & Enterprises), Bajaj Finserv, ACC, Laurus Labs, Dr. Lal Pathlabs, RailTel, Newgen Software and others. Follow for all the Live updates.
Laurus Labs consolidated net profit rises 19.46% in the March 2026 quarter
Sales rise 5.31% to Rs 1811.57 crore
Laurus Labs Q4 Results: Stock falls after revenue miss but margins expand
Laurus Labs' EBITDA margin for the period stood at 28.2% from 24.4% last year and largely in-line with the poll projection of 28%.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Momentum Stocks: Visa Steel hits upper circuit; Adani Ports, Laurus Labs at new high
Visa Steel, California Software, Omax Autos, Axiscades Technologies, Sterlite Technologies, DCM Shriram Fin were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.